248 related articles for article (PubMed ID: 26942567)
1. Expression profile and prognostic value of NNMT in patients with pancreatic cancer.
Xu Y; Liu P; Zheng DH; Wu N; Zhu L; Xing C; Zhu J
Oncotarget; 2016 Apr; 7(15):19975-81. PubMed ID: 26942567
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide N-methyltransferase overexpression is associated with Akt phosphorylation and indicates worse prognosis in patients with nasopharyngeal carcinoma.
Win KT; Lee SW; Huang HY; Lin LC; Lin CY; Hsing CH; Chen LT; Li CF
Tumour Biol; 2013 Dec; 34(6):3923-31. PubMed ID: 23838801
[TBL] [Abstract][Full Text] [Related]
3. Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer.
Li J; Yue H; Yu H; Lu X; Xue X
BMC Cancer; 2021 Jan; 21(1):67. PubMed ID: 33446144
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of Nicotinamide N-Methyltransferase (NNMT) in Cancer-associated Fibroblasts: A Potential Prognostic and Predictive Biomarker for Gastric Carcinoma.
Zhang L; Song M; Zhang F; Yuan H; Chang W; Yu G; Niu Y
J Histochem Cytochem; 2021 Mar; 69(3):165-176. PubMed ID: 33283625
[TBL] [Abstract][Full Text] [Related]
5. High stromal nicotinamide N-methyltransferase (NNMT) indicates poor prognosis in colorectal cancer.
Song M; Li Y; Miao M; Zhang F; Yuan H; Cao F; Chang W; Shi H; Song C
Cancer Med; 2020 Mar; 9(6):2030-2038. PubMed ID: 31989785
[TBL] [Abstract][Full Text] [Related]
6. Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance.
Wang L; Xiong L; Wu Z; Miao X; Liu Z; Li D; Zou Q; Yang Z
World J Surg Oncol; 2018 Jan; 16(1):11. PubMed ID: 29347944
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization.
Wang Y; Zeng J; Wu W; Xie S; Yu H; Li G; Zhu T; Li F; Lu J; Wang GY; Xie X; Zhang J
Breast Cancer Res; 2019 May; 21(1):64. PubMed ID: 31101119
[TBL] [Abstract][Full Text] [Related]
8. Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis.
Kim J; Hong SJ; Lim EK; Yu YS; Kim SW; Roh JH; Do IG; Joh JW; Kim DS
J Exp Clin Cancer Res; 2009 Feb; 28(1):20. PubMed ID: 19216803
[TBL] [Abstract][Full Text] [Related]
9. Effects of nicotinamide N-methyltransferase on PANC-1 cells proliferation, metastatic potential and survival under metabolic stress.
Yu T; Wang YT; Chen P; Li YH; Chen YX; Zeng H; Yu AM; Huang M; Bi HC
Cell Physiol Biochem; 2015; 35(2):710-21. PubMed ID: 25592232
[TBL] [Abstract][Full Text] [Related]
10. Analysis of nicotinamide N-methyltransferase in oral malignant melanoma and potential prognostic significance.
Mascitti M; Santarelli A; Sartini D; Rubini C; Colella G; Salvolini E; Ganzetti G; Offidani A; Emanuelli M
Melanoma Res; 2019 Apr; 29(2):151-156. PubMed ID: 30431528
[TBL] [Abstract][Full Text] [Related]
11. BIRC7 and KLF4 expression in benign and malignant lesions of pancreas and their clinicopathological significance.
Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
Cancer Biomark; 2016; 17(4):437-444. PubMed ID: 27802195
[TBL] [Abstract][Full Text] [Related]
12. Nicotinamide N-methyltransferase protein expression in renal cell cancer.
Zhang J; Xie XY; Yang SW; Wang J; He C
J Zhejiang Univ Sci B; 2010 Feb; 11(2):136-43. PubMed ID: 20104648
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Nicotinamide N-methyltransferase mainly covers stroma of colorectal cancer and correlates with unfavorable survival by its product 1-MNA.
Yang J; Tong Q; Zhang Y; Yuan S; Gao Y; Deng K; Wang Y; Lu J; Xie X; Zhang Z; Zhang J
J Cancer; 2021; 12(20):6170-6181. PubMed ID: 34539890
[No Abstract] [Full Text] [Related]
14. Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma.
Sartini D; Santarelli A; Rossi V; Goteri G; Rubini C; Ciavarella D; Lo Muzio L; Emanuelli M
Mol Med; 2007; 13(7-8):415-21. PubMed ID: 17622326
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma.
Ganzetti G; Sartini D; Campanati A; Rubini C; Molinelli E; Brisigotti V; Cecati M; Pozzi V; Campagna R; Offidani A; Emanuelli M
Melanoma Res; 2018 Apr; 28(2):82-88. PubMed ID: 29420365
[TBL] [Abstract][Full Text] [Related]
16. Expression and Clinical Significance of Nicotinamide N-Methyltransferase in Cervical Squamous Cell Carcinoma.
Akar S; Harmankaya İ; Uğraş S; Çelik Ç
Int J Gynecol Pathol; 2020 May; 39(3):289-295. PubMed ID: 31033801
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of nicotinamide
Dang L; Wang Y
Open Med (Wars); 2022; 17(1):292-303. PubMed ID: 35233465
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide N-methyltransferase expression in squamous cell carcinoma of the vulva.
Çelik ZE; Akar S; Fındık S; Aytekin E; Çelik Ç
J Obstet Gynaecol; 2022 Aug; 42(6):2325-2330. PubMed ID: 35499473
[TBL] [Abstract][Full Text] [Related]
19. Gastric Cancer With the Increased Nicotinamide N-methyltransferase-positive Stromal Cells Includes Unfavorable Prognosis-related Cancer-associated Fibroblasts.
Numakura S; Uozaki H
Anticancer Res; 2024 Apr; 44(4):1653-1660. PubMed ID: 38537979
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide N-methyltransferase expression and its association with phospho-Akt, p53 expression, and survival in high-grade endometrial cancer.
Akar S; Harmankaya İ; Uğraş S; Çelik Ç
Turk J Med Sci; 2019 Oct; 49(5):1547-1554. PubMed ID: 31652035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
